| Sunday, 23 October 2011 |
| |
|
| 10:20 |
Opening Remarks by Chair
Dr. Mansour Al-Zarouni, BSc (USA), MSc & PhD(UK), Consultant Medical & Molecular Microbiologist, Sharjah Medical District – Ministry of Health, Sharjah, UAE |
| |
|
SESSION 1: OVERVIEW
Moderator: Dr. Mansour Al-Zarouni, BSc (USA), MSc & PhD(UK), Consultant Medical & Molecular Microbiologist, Sharjah Medical District – Ministry of Health, Sharjah, UAE |
| |
|
| 10:30 |
Challenges and Opportunities for 2012 for Healthcare Epidemiology
Dr. Steven M. Gordon, Chairman, Department of Infectious Disease, Cleveland Clinic, President, Society of Healthcare Epidemiology of America, Cleveland, USA |
| |
|
SESSION 2: PANDEMICS AND RECENT OUTBREAKS
Moderator: Dr. Ágnes Sonnevend, MD, PhD, Assistant Professor, Consultant Clinical Microbiologist, Department of Microbiology and Immunology, FMHS, UAE University, Al Ain, UAE |
| |
|
| 11:00 |
EHEC Outbreak in Europe - Implications for the Middle East
Prof. Dr. Petra Gastmeier, Director, Institute for Hygiene and Environmental Medicine, Campus Benjamin Franklin, Charité - Universitätsmedizin, Berlin, Germany |
| |
|
| 11:30 |
Pandemic Influenza: How Prepared are we for the Next Round
Dr. Atef K. Soliman, PhD, Scientific Advisor, Viral & Zoonotic Diseases Research Program, U.S. Naval Medical Research Unit 3 (NAMRU-3), Cairo, Egypt |
| |
|
| 12:00 |
Lunch |
| |
|
SESSION 3: MRSA AND OTHER MDRO
Moderator: Prof. Ossama Rasslan, MD, PhD, Chair, International Section, APIC, Director, EMRNIC, President, ESIC, APIC/ Egypt Chapter, Secretary General, EPSA, Cairo, Egypt |
| |
|
| 13:30 |
Breaking the Vicious Cycle of Antibiotic Resistant Bacteria
Dr. Ashok Rattan, MD, MAMS, Chairman, Laboratory Medicine, The Medicity Hospital, Gurgaon, India |
| |
|
| 14:00 |
MRSA Management, 2011 Guidelines
Husain A. Alawadhi MD, Consultant Intensivist & Pulmonologist, Al Mafraq Hospital, Abu Dhabi, UAE |
| |
|
| 14:30 |
Clostridium difficile, More Challenging than Ever!
Dr. Mahmoud Shorman, Consultant, Infectious Diseases, Chairman of Infection Control Committee, King Fahad Specialist Hospital, Dammam, Saudi Arabia |
| |
|
| 15:00 |
Epidemiology of Carbapenem Resistance - Comparing the Local Situation with EU and US Experiences
Dr. Ágnes Sonnevend, MD, PhD, Assistant Professor, Consultant Clinical Microbiologist, Department of Microbiology and Immunology, FMHS, UAE University, Al Ain, UAE |
| |
|
| 15:30 |
Refreshment Break |
| |
|
SESSION 4: MYCOBACTERIA AND FUNGAL INFECTIONS
Moderator: Dr. Ashok Rattan, MD, MAMS, Chairman, Laboratory Medicine, The Medicity Hospital, Gurgaon, India |
| |
|
| 16:00 |
Hospital Acquired Tuberculosis
Dr. Ali Rabaan, M.Med.Sci, PhD, Head of Molecular Microbiology Laboratory, Saudi Aramco Medical Services Organization, Dhahran, Saudi Arabia |
| |
|
| 16:30 |
Invasive Fungal Infection – Emphasis on Recent Trends in Laboratory Diagnosis
Professor Eiman Mokaddas, Professor of Clinical Microbiology, Faculty of Medicine, Kuwait University, Kuwait |
| |
|
| 17:00 |
Q&A |
| |
|
| 17:30 |
Close of Day 1 |